_256_384.jpg)
Medical Device | November 25, 2024
Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
Genext Genomics can now offer comprehensive solutions that support the growth of India’s biotech ecosystem
Performed within GENEWIZ from Azenta Life Sciences' CLIA-certified and CAP-accredited state-of-the-art clinical genomics laboratory
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
The new facility significantly increases Siegfried’s R&D capacity to drive development excellence and further growth
CPHI & PMEC India Expo 2024 to bring over 50,000 industry professionals and 2,000 exhibitors under one roof
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
With 6 operation hubs and 18 offices across North America, Europe, and Asia, Indegene’s client base includes the world’s top 20 biopharma companies
This partnership is set to meet the growing demand for innovative life science research solutions in the Vietnamese market
Subscribe To Our Newsletter & Stay Updated
